BioH will want to make profit on top of the costs of purchasing off us, distribution costs, marketing, etc. I'm doubtful we'll be selling it to BioH for the price it's currently on the market for, otherwise BioH would have to mark up the sales price by multiples to make any money from this arrangement. Plus if they were going to pay current market value to buy from us, they wouldn't have dropped $23m in a license deal, they would've just bought out our entire stock.
For bulk manufacturing wholesale, I think Bedger's guesstimate of $50/unit was actually very reasonable.
Ann: OCC Signs Striate Global License And Manufacturing Agreement, page-209
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.0¢ | 38.5¢ | $110.6K | 280.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 22419 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 37015 | 1 |
View Market Depth
| Last trade - 15.58pm 16/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |